Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447635 · ClinicalTrials.gov registry record · NA
Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT07447635 is a NA study that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 600 participants.
The verdict
NCT07447635, a NA study, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.
Interventions
- BEHAVIORAL Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)
- BEHAVIORAL Quitline Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2029-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07447635
The ClinicalTrials.gov registry entry for NCT07447635 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) is the first listed.
NCT07447635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07447635 about?
NCT07447635 is a clinical study titled "Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors". This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder i...
What is the current status of trial NCT07447635?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-05-15. Estimated completion is 2029-12.
What interventions are being tested in trial NCT07447635?
The interventions under investigation include: Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) (BEHAVIORAL), Quitline Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT07447635?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.